Trademarkia Logo

Canada

C$
RYAPOSE
ABANDONED SECTION 36

on 12 Mar 2019

Last Applicant/ Owned by

ELI LILLY AND COMPANY

Lilly Corporate CenterIndianapolis, IN 46285

US

Serial Number

1839992 filed on 30th May 2017

RYAPOSE

Trademark usage description

pharmaceutical preparations namely pharmaceutical preparations for the treatment of alzheimer's disease, anxiety disorders, atopic dermatitis, autoimm Read More

Classification Information


Class [005]
Pharmaceutical preparations namely pharmaceutical preparations for the treatment of Alzheimer's disease, anxiety disorders, atopic dermatitis, autoimmune diseases and disorders, axial spondyloarthritis, bone and skeletal diseases and disorders namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, hip replacement surgery and knee replacement surgery, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders namely anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, gastrointestinal diseases and disorders, hypoglycemia, inflammation and inflammatory diseases and disorders namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders namely metabolic syndrome, migraines, multiple sclerosis, muscle diseases and disorders namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy, neurodegenerative diseases and disorders namely Huntington's disease and dementia, neurological disorders namely mild cognitive impairment, and multiple sclerosis, pain relief, Parkinson's disease, psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases


Classification kind code

11

Mark Details


Serial Number

1839992

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 6
on 12th Mar 2019
Abandoned - Section 36
Submitted for opposition 14
on 18th Dec 2018
Default Notice Sent
Submitted for opposition 15
on 30th May 2018
Correspondence Created
Submitted for opposition 22
on 3rd May 2018
Search Recorded
Submitted for opposition 20
on 3rd May 2018
Examiner's First Report
Submitted for opposition 31
on 5th Jun 2017
Formalized
Submitted for opposition 1
on 31st May 2017
Created
Submitted for opposition 30
on 30th May 2017
Filed